FDA Seizes Misbranded Drugs in Maine
Food and Drug Administration, U.S. Marshals seized drug products from Global Biotechnologies of Portland, Maine in late May.
According to the complaint, Global Biotechnologies has made claims on its website, in promotional materials and on the products' labels that its products can diagnose, cure, mitigate, treat or prevent human diseases. However, the company failed to provide adequate directions for use for its drug products, causing those products to be misbranded drugs in violation of the Federal Food, Drug and Cosmetic Act.
The FDA sent a warning letter to Global Biotechnologies, but the company had continued to make illegal claims that cause their products to be misbranded drugs. The company's products include Glucanol, Healthy Trac, Immunol and Lactopril.
Related Articles on Medication Safety:
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- How Physician Thinking Changes After Working in ACOs
- 2014 Financial Impact Analysis Doesn't Stop With CMS' Final Rule: Don't Neglect CMS NCCI Edits
- 4 Drivers of Recent M&A Activity in Healthcare
- 8 Reasons to Outsource Medical Billing Services
- 5 ICD-10 Transition Considerations Medical Practices Have Likely Not Thought About